Spinal Muscular Atrophy Trial, Recruiting NCT06539169 Sponsor: xCures Condition: Spinal Muscular Atrophy
Back to Spinal Muscular Atrophy

Spinal Muscular Atrophy Trial, Recruiting

NCT06539169
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have a rare disease (one that affects fewer than 200,000 people in the United States), whether it has been confirmed by a doctor or is only suspected. Examples include ALS, cystic fibrosis, sickle cell disease, Huntington's disease, Duchenne muscular dystrophy, early-onset Alzheimer's, Ehlers-Danlos syndrome, and several others (confirm with trial site for the full list).
  • You, or a legally authorized person acting on your behalf, are willing and able to give formal consent to participate in the study.
  • If you are a minor, you may also need to give your own agreement (called "assent") in addition to a parent or guardian giving consent.
  • Participation may be possible even after a person has passed away, if a legally authorized representative gives consent on their behalf, in line with U.S. federal and state laws.

Who may not be able to join:

  • You, or a legally authorized person acting on your behalf, are not able to give formal consent to participate.
  • You live outside of the United States and cannot provide access to your medical records.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 707-641-4475

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
xCures
Registry
ClinicalTrials.gov
Start date
10 June 2024
Est. completion
10 June 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Overall Survival (OS); Safety/tolerability of medications; Changes in normal development milestones; Changes in functional status; Changes in motor function; Changes in symptoms or clinical status

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov